Glaucoma is characterized by increased intraocular pressure and damage to the optic nerve, which may result in irreversible blindness. The drastic effects of this disease can be avoided if it is detected at an early stage. However, the condition is frequently detected at an advanced stage in the elderly population. Therefore, early-stage detection may save patients from irreversible vision loss. The manual assessment of glaucoma by ophthalmologists includes various skill-oriented, costly, and time-consuming methods. Several techniques are in experimental stages to detect early-stage glaucoma, but a definite diagnostic technique remains elusive. We present an automatic method based on deep learning that can detect early-stage glaucoma with very high accuracy. The detection technique involves the identification of patterns from the retinal images that are often overlooked by clinicians. The proposed approach uses the gray channels of fundus images and applies the data augmentation technique to create a large dataset of versatile fundus images to train the convolutional neural network model. Using the ResNet-50 architecture, the proposed approach achieved excellent results for detecting glaucoma on the G1020, RIM-ONE, ORIGA, and DRISHTI-GS datasets. We obtained a detection accuracy of 98.48%, a sensitivity of 99.30%, a specificity of 96.52%, an AUC of 97%, and an F1-score of 98% by using the proposed model on the G1020 dataset. The proposed model may help clinicians to diagnose early-stage glaucoma with very high accuracy for timely interventions.
Brain tumor is a fatal disease, caused by the growth of abnormal cells in the brain tissues. Therefore, early and accurate detection of this disease can save patient’s life. This paper proposes a novel framework for the detection of brain tumor using magnetic resonance (MR) images. The framework is based on the fully convolutional neural network (FCNN) and transfer learning techniques. The proposed framework has five stages which are preprocessing, skull stripping, CNN‐based tumor segmentation, postprocessing, and transfer learning‐based brain tumor binary classification. In preprocessing, the MR images are filtered to eliminate the noise and are improve the contrast. For segmentation of brain tumor images, the proposed CNN architecture is used, and for postprocessing, the global threshold technique is utilized to eliminate small nontumor regions that enhanced segmentation results. In classification, GoogleNet model is employed on three publicly available datasets. The experimental results depict that the proposed method is achieved average accuracies of 96.50%, 97.50%, and 98% for segmentation and 96.49%, 97.31%, and 98.79% for classification of brain tumor on BRATS2018, BRATS2019, and BRATS2020 datasets, respectively. The outcomes demonstrate that the proposed framework is effective and efficient that attained high performance on BRATS2020 dataset than the other two datasets. According to the experimentation results, the proposed framework outperforms other recent studies in the literature. In addition, this research will uphold doctors and clinicians for automatic diagnosis of brain tumor disease.
1 August 2018 in Artificial Intelligence in Medicine
The Central Serous Retinopathy (CSR) or Central Serous Chorioretinopathy (CSC) is a significant disease that causes blindness and vision loss among in millions of people in the world. It transpires as a result of accumulation of watery fluids behind the retina. Therefore, detection of CSR at early stages allows taking preventive measures to avert any impairment to the human eye. Traditionally, several manual methods for detecting CSR have been developed in the past; however, they have shown to be imprecise and unreliable. Consequently, due to Artificial Intelligence (AI) services in the medical field, including automated CSR detection, it is now possible to detect and cure this disease. This review assessed a variety of innovative technologies and researches that contribute to the automatic detection of CSR. In this review, various CSR disease detection techniques, broadly classified into two categories: a) CSR detection based on classical imaging technologies, and b) CSR detection based on Machine/Deep Learning methods, have been reviewed after an elaborated evaluation of 29 different relevant articles. Additionally, it also goes over the advantages, drawbacks and limitations of a variety of traditional imaging techniques, such as Optical Coherence Tomography Angiography (OCTA), Fundus Imaging and more recent approaches that utilize Artificial Intelligence techniques. Finally, it is concluded that the most recent Deep Learning (DL) classifiers are found to deliver accurate, fast, and reliable CSR detection. However, there is a need of more researches on publically available datasets to improve computation complexity for the reliable detection and diagnosis of CSR disease.
This paper presents a dataset that contains 100 high quality fundus images which are acquired from Armed Forces Institute of Ophthalmology (AFIO), Rawalpindi Pakistan. The dataset has been marked by four expert ophthalmologists to aid clinicians and researchers in screening hypertensive retinopathy, diabetic retinopathy and papilledema cases. Moreover, it contains highly detailed annotations for retinal blood vascular patterns, arteries and veins to calculate arteriovenous ratio (AVR), optic nerve head (ONH) region and other retinal anomalies such as hard exudates and cotton wool spots etc. The dataset is extremely useful for the researchers who are working in the ophthalmic image analysis.